Aclaris Therapeutics to Participate in Three November Healthcare Conferences

Core Insights - Aclaris Therapeutics, Inc. will participate in three healthcare conferences in November 2025, showcasing its focus on immuno-inflammatory diseases [1][4]. Company Overview - Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel product candidates for patients with immuno-inflammatory diseases who currently lack satisfactory treatment options [3]. - The company has a multi-stage portfolio of product candidates supported by a robust research and development engine [3]. Upcoming Events - On November 12, 2025, at 11:00 AM EST, Aclaris' CEO Dr. Neal Walker and senior leadership will participate in a fireside chat at the Guggenheim 2 Annual Healthcare Conference in Boston, MA [4]. - On the same day at 1:20 PM EST, Aclaris' President and COO Dr. Hugh Davis will also participate in a fireside chat at the Stifel 2025 Healthcare Conference in New York, NY [4]. - On November 17, 2025, at 2:00 PM GMT (9:00 AM EST), Dr. Walker will engage in a fireside chat at the Jefferies Global Healthcare Conference in London, UK [4].